134 related articles for article (PubMed ID: 19409429)
1. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD.
Watkins CL; Brennan P; Fegan C; Takayama K; Nakase I; Futaki S; Jones AT
J Control Release; 2009 Dec; 140(3):237-44. PubMed ID: 19409429
[TBL] [Abstract][Full Text] [Related]
2. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
3. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
[TBL] [Abstract][Full Text] [Related]
4. Acylation of octaarginine: Implication to the use of intracellular delivery vectors.
Katayama S; Hirose H; Takayama K; Nakase I; Futaki S
J Control Release; 2011 Jan; 149(1):29-35. PubMed ID: 20144669
[TBL] [Abstract][Full Text] [Related]
5. Cell-penetrating peptide-conjugated XIAP-inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation.
Sasaki Y; Minamizawa M; Ambo A; Sugawara S; Ogawa Y; Nitta K
FEBS J; 2008 Dec; 275(23):6011-21. PubMed ID: 19016849
[TBL] [Abstract][Full Text] [Related]
6. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
7. Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).
Takayama K; Nakase I; Michiue H; Takeuchi T; Tomizawa K; Matsui H; Futaki S
J Control Release; 2009 Sep; 138(2):128-33. PubMed ID: 19465072
[TBL] [Abstract][Full Text] [Related]
8. Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate.
Takeuchi T; Kosuge M; Tadokoro A; Sugiura Y; Nishi M; Kawata M; Sakai N; Matile S; Futaki S
ACS Chem Biol; 2006 Jun; 1(5):299-303. PubMed ID: 17163758
[TBL] [Abstract][Full Text] [Related]
9. Arginine carrier peptide bearing Ni(II) chelator to promote cellular uptake of histidine-tagged proteins.
Futaki S; Niwa M; Nakase I; Tadokoro A; Zhang Y; Nagaoka M; Wakako N; Sugiura Y
Bioconjug Chem; 2004; 15(3):475-81. PubMed ID: 15149174
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
Manceur A; Wu A; Audet J
Anal Biochem; 2007 May; 364(1):51-9. PubMed ID: 17379177
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
Chugh A; Eudes F; Shim YS
IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
[TBL] [Abstract][Full Text] [Related]
12. Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation.
Cryan SA; Devocelle M; Moran PJ; Hickey AJ; Kelly JG
Mol Pharm; 2006; 3(2):104-12. PubMed ID: 16579639
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic delivery of a p16-peptide oligoarginine conjugate for inhibiting proliferation of MCF7 cells.
Zaro JL; Shen WC
J Control Release; 2005 Nov; 108(2-3):409-17. PubMed ID: 16202470
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cellular uptake and cytotoxicity studies of organometallic bioconjugates of the NLS peptide in Hep G2 cells.
Noor F; Kinscherf R; Bonaterra GA; Walczak S; Wölfl S; Metzler-Nolte N
Chembiochem; 2009 Feb; 10(3):493-502. PubMed ID: 19115329
[TBL] [Abstract][Full Text] [Related]
15. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
[TBL] [Abstract][Full Text] [Related]
16. Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption.
Shiraishi T; Nielsen PE
Nat Protoc; 2006; 1(2):633-6. PubMed ID: 17406290
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
18. Protein delivery by the cell-penetrating peptide YTA2.
Myrberg H; Lindgren M; Langel U
Bioconjug Chem; 2007; 18(1):170-4. PubMed ID: 17226970
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cellular uptake using 22 CPPs in 4 different cell lines.
Mueller J; Kretzschmar I; Volkmer R; Boisguerin P
Bioconjug Chem; 2008 Dec; 19(12):2363-74. PubMed ID: 19053306
[TBL] [Abstract][Full Text] [Related]
20. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity.
Henriques ST; Castanho MA
J Pept Sci; 2008 Apr; 14(4):482-7. PubMed ID: 18181239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
